RE:RE:RE:RE:Excerpts from the Final Prospectus dated Nov 26thDefinitely, I'm not sure what happened but for some reason sedar only showed the Final Prospectus to me today. Maybe it's my cache, cookies and browser histroy but it's not the first time I find something in sedar days later but I check every day. Maybe I just fell into the basher distraction trap and completely missed it because of all the garbage they've been posting here. They're actually quite good at misdirection unfortunately, gets even me off my research.
capebretongirl wrote: Jonnyboy85 wrote: During the first six weeks of COVID-19 testing, StageZero performed approximately
5,000 COVID-19 Tests. To the end of October, StageZero had performed approximately
13,000 COVID-19 Tests. The initial orders StageZero entered into for COVID-19 testing was with five (5) client groups; it is now performing tests for approximately fifty
(50) client groups and adding more. New groups are being added on an ongoing basis. StageZero anticipates increasing demand for testing over the next several months and through the winter
as planned COVID-19 testing commences according to the timetables set by these client groups. The projected growth in COVID-19 testing is occurring and is on pace with StageZero’s expectations with significant growth anticipated on a quarter over quarter basis in order to meet the projected revenue. Testing revenue is therefore expected to show
significant increases over consecutive quarters for the next three (3) to four (4) quarters. Jonnyboy85 wrote: (currently, StageZero has testing supplies and inputs available to process approximately
30,000 COVID-19 Tests)
Jonnyboy85 wrote: The Company has received interest from the City of Alpharetta, Georgia, United States, Phlebfinders and UDoTest, among others, to have the Company provide COVID-19 Tests to their respective workforces, clients and residents. In addition, the Company is providing testing for the employees and court system of a large county in the United States, an airline, Ichor Blood Services Inc. (“Ichor”), a film company, urgent care centres, a global visa and travel group as well as a number of other groups
"The Company plans on introducing Aristotle® to the market by Q1 2021."
"As of October 2020, the Company’s testing capacity is in excess of 1,000 tests per day (comprising all types of COVID-19 Tests) and is trending towards 3,000 tests per day."
Its all very encouraging isn't it? If this timeline and numbers stand we will be in wonderful shape for revenue beyond our dreams - just keep Aristotle on schedule so we can have a Covid -Cancer double win overlap scenario for awhile.